BioPharma Engages LexaGene in Second Feasibility Study

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

TSX Venture Exchange Stock Maintenance Bulletins
LexaGene Files for Chapter 7 Bankruptcy
IIROC Trading Halt - LXG
LexaGene Holdings Announces Results of February 8, 2023 Annual General Meeting
LexaGene Provides Update on BioPharma Sector
LexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers
LexaGene Holdings Proposes to Amend Warrants Terms
LexaGene Successfully Completes Statement of Work for BioPharma Company

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.